» Authors » Matitiahu Berkovitch

Matitiahu Berkovitch

Explore the profile of Matitiahu Berkovitch including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 137
Citations 953
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Siegel E, Lamb M, Goldsmith J, Rundle A, Neophytou A, Berkovitch M, et al.
Am J Epidemiol . 2025 Mar; PMID: 40036367
In environmental epidemiology, we use systematic reviews to evaluate the evidence of exposure-outcome relationships with an eye towards regulation. Conflicting results across studies thwart consensus on toxicity. In humans, only...
2.
Israel A, Raz I, Green I, Golan-Cohen A, Berkovitch M, Magen E, et al.
Diabetes Res Clin Pract . 2024 Dec; 219():111965. PMID: 39710070
Aims: To assess the impact of Glucose-6-phosphate dehydrogenase (G6PD) deficiency, an enzymatic deficiency prevalent in individuals of African or Asian descent, on Hemoglobin A1c (HbA1c) levels, diabetes medication purchases, and...
3.
Michael T, Solt I, Daniel S, Levy A, Hochwald O, Borenstein-Levin L, et al.
Int J Hyg Environ Health . 2024 Dec; 264:114493. PMID: 39631195
Background: Several studies have associated prenatal exposure to volatile organic compounds (VOCs) with adverse health outcomes among newborns. However, little is known about the associations of VOCs at relatively low...
4.
Nissimov S, Kohn A, Keidar R, Livne A, Shemer M, Gover A, et al.
Paediatr Drugs . 2024 Nov; 27(2):247-255. PMID: 39578320
Introduction: Less invasive surfactant administration (LISA) involves delivering surfactant to a spontaneously breathing infant by passing a thin catheter through the vocal cords and has become the preferred method for...
5.
Israel A, Raz I, Vinker S, Magen E, Green I, Golan-Cohen A, et al.
N Engl J Med . 2024 Aug; 391(6):568-569. PMID: 39115068
No abstract available.
6.
David A, Stolar O, Berkovitch M, Kohn E, Hazan A, Waissengreen D, et al.
Cannabis Cannabinoid Res . 2024 Jul; PMID: 39047052
The literature supports the benefits of medical cannabis for core and comorbid symptoms in autistic individuals and anxiety-related symptoms in individuals without autism. However, no study has specifically investigated how...
7.
Gueta I, Ross J, Sheinberg R, Keidar R, Livne A, Berkovitch M, et al.
Heliyon . 2024 Jul; 10(13):e33633. PMID: 39040426
Background: In-utero phthalate exposure was shown to be associated with shortened anogenital distance (AGD) in male newborns, but findings among female are inconsistent. While phthalate exposure among pregnant women in...
8.
David A, Stolar O, Berkovitch M, Kohn E, Waisman-Nitzan M, Hartmann I, et al.
Med Cannabis Cannabinoids . 2024 Jul; 7(1):68-79. PMID: 39015610
Introduction: Medical cannabis treatment for autistic children has recently become popular, and studies have focused on examining the treatment's effects on children's symptom presentation, reported side effects, and dropout rates....
9.
Berezovsky E, Kohn E, Britzi M, Efreim S, Berlin M, Oppenheimer S, et al.
Reprod Toxicol . 2024 Jul; 128:108658. PMID: 38972363
This study aimed to evaluate associations between prenatal and childhood exposure to phthalates and prenatal exposure to polychlorinated biphenyls (PCBs) and the development of 4-year-old children. Urinary metabolites of five...
10.
Benassayag Kaduri N, Hazan A, De-Haan T, Kohn E, Berkovitch M, Berlin M
Psychiatry Res . 2024 Jun; 339:116047. PMID: 38908263
Attention deficit hyperactive disorder (ADHD) medication use rises among women of childbearing age and during pregnancy. Little is known on the safety of amphetamine stimulants for ADHD treatment during breastfeeding....